InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,659.60
(
-2.28%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.15
(
0.04%
)
Bitcoin
57,054.65
(
-0.52%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

amylucio

Send PM Follow Ignore
Followers 0
Posts 1
Boards Moderated 0
Alias Born 10/25/2014

amylucio

Re: frontiers post# 182994

Saturday, 10/25/2014 7:47:08 PM

Saturday, October 25, 2014 7:47:08 PM

Post# of 252581
very nice analysis on ACH3422. I totally agree with you for all the points.

The 20140309189 patent shows Alios 6037, which has also 2 deuteriums at 5' position. Did you check further their patents? any conflict?

Alios Bio. has recently published a paper. They have checked the potency of the "non-deuterium verison" of ACH3422-TP, and the potency is similar to Sovaldi-TP. I feel ACH3422 should have similar potency as Sovaldi, but more toxic. But anyway, for P1, this difference in toxic is not so important.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up